Comparison between Bio Medica Laboratories IPO and Sihora Industries IPO.
Bio Medica Laboratories IPO is a SME Fixed Price IPO proposed to list at NSE SME while Sihora Industries IPO is a SME Fixed Price proposed to list at BSE SME.
| Bio Medica Laboratories IPO | Sihora Industries IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Fixed Price |
| Listing At | NSE SME | BSE SME |
| Lead Managers | Narnolia Financial Services Ltd. | Sobhagya Capital Options Pvt.Ltd. |
| Registrar | Skyline Financial Services Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Prabhat Financial Services Ltd. | Aftertrade Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Bio Medica Laboratories IPO is up to ₹49.80 Cr whereas the issue size of the Sihora Industries IPO is up to ₹10.03 Cr. The final issue price of Bio Medica Laboratories IPO is ₹139.00 per share and of Sihora Industries IPO is ₹66.00 per share.
| Bio Medica Laboratories IPO | Sihora Industries IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹132.00 per share | |
| Issue Price (Upper) | ₹139.00 per share | |
| Issue Price (Final) | ₹139.00 per share | ₹66.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 1000 shares | 2000 shares |
| Fresh Issue Size | 32,06,000 shares | 15,20,000 shares |
| Fresh Issue Size (Amount) | up to ₹44.56 Cr | up to ₹10.03 Cr |
| OFS Issue Size | 3,77,000 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹5.24 Cr | up to ₹0.00 Cr |
| Issue Size Total | 35,83,000 shares | 15,20,000 shares |
| Issue Size Total (Amount) | up to ₹49.80 Cr | up to ₹10.03 Cr |
Bio Medica Laboratories IPO opens on May 21, 2026, while Sihora Industries IPO opens on Oct 10, 2025. The closing date of Bio Medica Laboratories IPO and Sihora Industries IPO is May 25, 2026, and Oct 14, 2025, respectively.
| Bio Medica Laboratories IPO | Sihora Industries IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | May 21, 2026 | Oct 10, 2025 |
| Issue Close | May 25, 2026 | Oct 14, 2025 |
| Basis Of Allotment (Tentative) | May 26, 2026 | Oct 15, 2025 |
| Initiation of Refunds (Tentative) | May 27, 2026 | Oct 16, 2025 |
| Credit of Share (Tentative) | May 27, 2026 | Oct 16, 2025 |
| Listing date (Tentative) | May 29, 2026 | Oct 17, 2025 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Bio Medica Laboratories IPO P/E ratio is 13.03, as compared to Sihora Industries IPO P/E ratio of 13.14.
| Bio Medica Laboratories IPO | Sihora Industries IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 96.84 | 100 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 69.97 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 13.03 | 13.14 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹174.79 Cr. | ₹35.16 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 99.59 | 35.60 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 48.20 | 31.93 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.02 | 0.98 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹10.67 | ₹5.02 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 99.59 | 35.60 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Bio Medica Laboratories IPO Retail Individual Investors (RII) are offered 17,92,000 shares while in Sihora Industries IPO retail investors are offered 17,92,000 shares. Qualified Institutional Buyers (QIB) are offered 36,000 shares in Bio Medica Laboratories IPO and 0 shares in Sihora Industries IPO.
| Bio Medica Laboratories IPO | Sihora Industries IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 1,89,000 shares | 80,000 shares |
| QIB | 36,000 shares | 0 shares |
| NII | 17,55,000 shares | 7,60,000 shares |
| RII | 17,92,000 shares | 7,60,000 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 35,83,000 shares | 15,20,000 shares |
Bio Medica Laboratories IPO subscribed 2.26x in total, whereas Sihora Industries IPO subscribed 1.27x.
| Bio Medica Laboratories IPO | Sihora Industries IPO | |
|---|---|---|
| QIB (times) | 15.94x | |
| NII (times) | 1.30x | 1.18x |
| Big NII (times) | 0.86x | |
| Small NII (times) | 2.19x | |
| RII (times) | 2.92x | 1.37x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 2.26x | 1.27x |
